Clinical Trial Update: Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating camrelizumab in combination with apatinib and NK cells for advanced hepatocellular carcinoma is ongoing, with status currently unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN